Benzinga

64754.300.0609%

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Benzinga Edge
Benzinga Pro
Benzinga Research
Benzinga APIs
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Events Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Options Profit Calculator

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Covered Call Calculator

Cash-Secured Put Calculator

Long Call Calculator

Long Put Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

64754.300.0609%

AstraZeneca PLC Stock News

AZNNYSE

Trade with Public

Trade with Public

$168.90

-0.39-0.23%

At close: Jul 17, 5:00 PM EST

$169.62

0.720.43%

After Hours: Jul 17, 7:34 PM EST

OverviewNewsEarnings Events Options Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Latest AstraZeneca Stock News | NYSE:AZN | Benzinga

Get the latest news on AstraZeneca stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on AstraZeneca performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, July 17, 2026

PRO
'Biotech Abivax re-engages investment bank Ce...
Benzinga Newsdesk

Wednesday, July 15, 2026

PRO
Kairos Pharma Announces Interim Safety Data F...
Benzinga Newsdesk

Tuesday, July 14, 2026

PRO
AstraZeneca shares are trading lower after th...
Benzinga Newsdesk
PRO
AstraZeneca Announced Earlier It Entered Excl...
Benzinga Newsdesk

Friday, July 10, 2026

Ionis, AstraZeneca Stumble in ATTR-CM Trial as Rivals Stand to Gain
Vandana Singh

Thursday, July 09, 2026

Ionis, AstraZeneca Pivotal Heart Disease Drug Flunks
Vandana Singh
Levi Strauss, Ionis Pharmaceuticals, Gloo Holdings And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
Avi Kapoor
PRO
AstraZeneca shares are trading lower after th...
Benzinga Newsdesk
PRO
Ionis And AstraZeneca's CARDIO-TTRansform Pha...
Benzinga Newsdesk

Wednesday, July 08, 2026

Sino Biopharma Accelerates Global Growth With GSK, AstraZeneca Partnerships
Vandana Singh
PRO
'AstraZeneca, Daiichi Near UK Price Deal for ...
Benzinga Newsdesk

Tuesday, July 07, 2026

PRO
Helix Partners With AstraZeneca Over Access T...
Benzinga Newsdesk

Sunday, July 05, 2026

Warren Says Trump's Law Pushed 2 Million-Plus Children Off Medicaid, CHIP Across States
Benzinga Neuro

Thursday, July 02, 2026

Abbisko, AstraZeneca Team Up on Lung Cancer Drug Combo After China Trial Clearance
Vandana Singh
PRO
AstraZeneca shares are trading higher after t...
Benzinga Newsdesk
PRO
CSPC Pharmaceutical Earlier Announced Strateg...
Benzinga Newsdesk
PRO
Reported Earlier, Abbisko And AstraZeneca Joi...
Benzinga Newsdesk

Monday, June 29, 2026

AstraZeneca Advances Rare Bone Disease Pipeline While Enhertu Expands In Europe
Vandana Singh

Friday, June 26, 2026

PRO
EU CHMP Recommends Approval Of Daiichi Sankyo...
Benzinga Newsdesk

Monday, June 22, 2026

Less Volume, More Premium: Post-Ozempic Economics Are Killing The Quantity Model
Stjepan Kalinic

Monday, June 15, 2026

This Aggressive Prostate Cancer Finally Has Targeted Treatment — AstraZeneca Wins FDA Nod
Vandana Singh
PRO
The FDA Accepts And Grants Priority Review To...
Benzinga Newsdesk

Friday, June 12, 2026

PRO
AstraZeneca Announces Truqap Combination Appr...
Benzinga Newsdesk

Tuesday, June 09, 2026

AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials
Vandana Singh

Monday, June 08, 2026

PRO
'AstraZeneca's Obesity Pill Matches Rivals In...
Benzinga Newsdesk
AstraZeneca Reports Significant Proteinuria Reduction With Ultomiris In Rare Kidney Disease
Vandana Singh

Thursday, June 04, 2026

PRO
Shares of pharmaceutical companies are tradin...
Benzinga Newsdesk

Tuesday, June 02, 2026

AstraZeneca Highlights Sustained Survival Benefit In Advanced Breast Cancer Study
Vandana Singh
PRO
AstraZenica To Present Updated Phase III SERE...
Benzinga Newsdesk

Monday, June 01, 2026

AstraZeneca Sees Encouraging Survival Trend In Liver Cancer Trial
Vandana Singh
PRO
AstraZeneca's IMFINZI Presents Results From E...
Benzinga Newsdesk

Friday, May 29, 2026

Pfizer Strikes Up To $10.5 Billion Deal With China's Innovent Biologics To Develop Next-Gen Cancer Therapies
Namrata Sen
PRO
Reported Earlier, Astrazeneca's Imfinzi (Dur...
Benzinga Newsdesk

Thursday, May 28, 2026

PRO
FDA Approves Durvalumab In Combination With B...
Benzinga Newsdesk

Friday, May 22, 2026

PRO
Daiichi Sankyo, AstraZeneca's Datroway Receiv...
Benzinga Newsdesk
PRO
Enhertu, Jointly Developed, Commercialized By...
Benzinga Newsdesk
PRO
AstraZeneca To Present Phase III Data In Live...
Benzinga Newsdesk

Tuesday, May 19, 2026

Supreme Court Hands Major Blow To Big Pharma's Fight Against Biden-Era Medicare Drug Pricing Law
Tanya Rawat

Monday, May 18, 2026

AstraZeneca Scores Key FDA Wins Across Cardiovascular And Oncology Portfolios
Vandana Singh
PRO
'Drug Companies Spurned by Supreme Court on P...
Benzinga Newsdesk
PRO
AstraZeneca's BAXFENDY Approved In US As Aldo...
Benzinga Newsdesk
PRO
AstraZeneca's Baxfendy Wins FDA Approval As F...
Benzinga Newsdesk
PRO
Reported Friday, AstraZeneca And Daiichi Sank...
Benzinga Newsdesk

Saturday, May 16, 2026

FDA Drug Chief Tracey Hoeg Fired Days After After Marty Makary's Exit— Says Order Came From 'Way Above'
Mohd Haider

Thursday, May 14, 2026

AstraZeneca's Imfinzi Combo Shows Survival Benefit In Pivotal Bladder Cancer Study
Vandana Singh
PRO
AstraZeneca Says Perioperative IMFINZI Plus I...
Benzinga Newsdesk
Trump's Drug Pricing Plan Gains Surprise Democratic Ally— Peter Welch Vows To 'Make It Happen'
Tanya Rawat

Wednesday, May 13, 2026

Owkin Expands AstraZeneca Collaboration Around K Pro AI Platform
Vandana Singh

Tuesday, May 12, 2026

AstraZeneca's Rare Disease Drug Shows Reduced Dependence On Calcium Supplements
Vandana Singh
PRO
Astrazeneca's Eneboparatide (AZP-3601) In CAL...
Benzinga Newsdesk

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved

Earnings: Q2 2026 Earnings in 8 days from now on Mon Jul 27th, before the market open